Cargando…
GLUT1 gene is a potential hypoxic marker in colorectal cancer patients
BACKGROUND: Tumor hypoxia is an important factor related to tumor resistance to radiotherapy and chemotherapy. This study investigated molecules synthesized in colorectal cancer cells during hypoxia to explore the possibility of developing molecular probes capable of detecting cell death and/or the...
Autores principales: | Chung, Fu-Yen, Huang, Ming-Yii, Yeh, Ching-Sheng, Chang, Hui-Jen, Cheng, Tian-Lu, Yen, Li-Chen, Wang, Jaw-Yuan, Lin, Shiu-Ru |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087329/ https://www.ncbi.nlm.nih.gov/pubmed/19619276 http://dx.doi.org/10.1186/1471-2407-9-241 |
Ejemplares similares
-
Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome
por: Huang, Ming-Yii, et al.
Publicado: (2013) -
Significant Overexpression of DVL1 in Taiwanese Colorectal Cancer Patients with Liver Metastasis
por: Huang, Ming-Yii, et al.
Publicado: (2013) -
DPYD, TYMS, TYMP, TK1, and TK2 Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy
por: Huang, Ming-Yii, et al.
Publicado: (2013) -
ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: A preliminary study
por: Huang, Ming-Yii, et al.
Publicado: (2008) -
Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review
por: Huang, Chun-Ming, et al.
Publicado: (2022)